Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study

All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129

(2013) Dan Douer et al.   LEUKEMIA RESEARCH

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

(2013) Francesco Lo-Coco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Acute myeloid leukemia in the real world: why population-based registries are needed

(2012) G. Juliusson et al.   BLOOD

Acute promyelocytic leukemia: A population-based study on incidence and survival in the United States, 1975-2008

(2012) Yiming Chen et al.   CANCER

Underreporting of Myeloid Malignancies by United States Cancer Registries

(2012) B. M. Craig et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

(2011) J. H. Park et al.   BLOOD

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007

(2011) G. M. Dores et al.   BLOOD

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

(2011) H. Iland et al.   HAEMATOLOGICA

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry

(2011) S Lehmann et al.   LEUKEMIA

Geographic Variation in Physicians' Responses to a Reimbursement Change

(2011) Mireille Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

(2010) M. A. Sanz et al.   BLOOD

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

(2009) L. Ades et al.   BLOOD

The 2008 World Health Organization classification system for myeloproliferative neoplasms

(2009) Ayalew Tefferi et al.   CANCER

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

(2008) M. A. Sanz et al.   BLOOD